| MDL | - |
|---|---|
| Molecular Weight | 257.71 |
| Molecular Formula | C12H16ClNO3 |
| SMILES | O=C(OCC1=CC=CC=C1)CCC(CN)=O.[H]Cl |
|
Human Endogenous Metabolite |
5-ALA benzyl ester hydrochloride (Benzyl-ALA hydrochloride) (0.6-0.12 mM; 3 h) induces protoporphyrin IX (PPIX) accumulation in colon carcinoma cell lines SW480 [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Reducing the dose of 5-ALA benzyl ester hydrochloride (31 mg/kg; i.v. ; 1 hours) results in a dose-dependent reduction in tumour porphyrin levels [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Female CBA/Gy mouse (CaNT tumour model) [3] |
| Dosage: | 31 mg/kg |
| Administration: | i.v. ; 1 hours |
| Result: | Reducing the dose of 5-ALA benzyl ester hydrochloride resulted in a dose-dependent reduction in the concentration of porphyrins accumulating in the CaNT tumour. |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 250 mg/mL ( 970.08 mM ; Need ultrasonic)
H 2 O : 100 mg/mL ( 388.03 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 3.8803 mL | 19.4017 mL | 38.8033 mL |
| 5 mM | 0.7761 mL | 3.8803 mL | 7.7607 mL |
| 10 mM | 0.3880 mL | 1.9402 mL | 3.8803 mL |
Add each solvent one by one: PBS
Solubility: 100 mg/mL (388.03 mM); Clear solution; Need ultrasonic
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.08 mg/mL (8.07 mM); Clear solution
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.08 mg/mL (8.07 mM); Clear solution